Observational Study Collecting Cancer Patient Data from the ROC Platform in Campania Region
Retrospective and Prospective Multicenter Cancer Registry
Led by National Cancer Institute, Naples · Updated on 2025-12-22
15000
Participants Needed
17
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
This research focuses on cancer patients registered in the ROC platform, a multicenter database in the Campania region. It aims to gather and analyze data retrospectively and prospectively to improve understanding of cancer patient outcomes and care. The study seeks to monitor the ROC platforms performance and provide insights into cancer epidemiology, treatment, and healthcare management in this region, which has worse oncological outcomes compared to other Italian areas.
Participants come from two groups those already recorded in the ROC platform since its activation in November 2018 until the studys start, and new patients entering the platform after ethical approval. Data collection covers a wide range of information, including tumor incidence, treatment strategies, diagnostic activities, and adherence to clinical guidelines. These data are collected continuously and analyzed at set intervals over several years.
During the study, researchers will evaluate many outcomes such as tumor incidence and prevalence, timing between diagnostic and therapeutic activities, patient quality of life, costs related to care inefficiencies, and patient satisfaction. Assessments will occur regularly up to five years or longer, depending on the measure. This ongoing monitoring aims to provide comprehensive knowledge to improve cancer care and decision-making for patients in the Campania region.
CONDITIONS
Brief Title
The ONCOCAMP Study
Research Team
S
Sandro Pignata, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surveillance
Duration - Up to 5 years
Participants who are registered in the ROC platform are observed over time to monitor cancer-related data and outcomes.
Assessments every 2 to 6 months depending on data type, with some yearly evaluations
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Study of a Decision Support Program for Older Adults 60 with Acute Myeloid Leukemia and Their Caregivers
Evaluating a New Ureteric Stent to Reduce Blockages, Infections, and Improve Outcomes in Adults with Kidney Stones or Cancer
Phase 12 Study of BIO-106 Alone or With Pembrolizumab for Advanced Solid Tumors and Cancers
Phase 1 Study of Oral NST-628 Tablets to Test Safety and Effectiveness in Adults with Advanced Solid Tumors Having MAPK Pathway or Other Genetic Mutations
Testing a Mobile Health App with Nurse Support to Manage Symptoms in Children Ages 9 to 16 Who Are Early Cancer Survivors and Their Caregivers
Study of Tolerance and Acceptance of Bolus Tube Feeding With Food Blends in Children and Adults
for Nutritional Management of Disease-Related Malnutrition
Study of Advanced Integrative Oncology Treatment in Adults and Children With Cancer
Tracking Survival and Treatment Outcomes Over Five Years
Implementation of the Ask Questions About Clinical Trials ASQ-CT Brochure to Improve Communication and Invitations for Clinical Trials
Study of Cardiac Coherence Breathing and Medical Hypnosis to Reduce Anxiety Before Cancer Surgery
Understanding Immune-Related Side Effects in Cancer Patients Treated with Checkpoint Inhibitors
Optimizing Nutritional Care with Machine Learning: Identifying Sarcopenia Risk Through Body Composition Parameters in Cancer Patients-Insights from the NUTritional and Sarcopenia RIsk SCREENing Project (NUTRISCREEN).
Giuseppe Porciello, Teresa Di Lauro, Assunta Luongo...